Biotricity is trading 14.82% down at $0.05, with no clear company-specific announcement or event identified to explain the October 5, 2026 decline. - The company’s news archive lists its latest release as February 11, 2026. - The S&P 500 and Nasdaq are higher in a mixed-to-positive broader market; available evidence does not establish a market-wide explanation for the drop. - Reported volume was 26.61K, below the cited average daily volume of 87.34K.